Casey Paleos, MD
Casey Paleos, MD is a psychiatrist and researcher with over a decade of experience in the use of psychedelic medicines for the treatment of mental illness. He was a study therapist in the landmark Psilocybin Cancer Anxiety Study at NYU, a Co-Principal Investigator in the NYU-Bellevue Ketamine for Depression Study and has been treating patients in his private practice with both ketamine infusion therapy and ketamine-assisted psychotherapy since 2016. He serves as Scientific Director at Mindbloom, Inc., and is a co-founder of Nautilus Sanctuary, a non-profit psychedelic research and clinical institution based in New York City.
Financial: Dr. Casey Paleos has employment relationships with Nautilus Sanctuary, Nautilus Psychiatric Services, PLLC, and Multidisciplinary Association for Psychedelic Studies. He is the science director of Mindbloom, Inc. and receives a speaking honorarium from Fluence. Dr. Paleos receives a speaking honorarium from Psychotherapy Networker and PESI, Inc.
Non-financial: Dr. Casey Paleos has no relevant non-financial relationships.